These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 7248151

  • 1. Mice, men, mustard and methylated xanthines: the potential role of caffeine and related drugs in the sensitization of human tumours to alkylating agents.
    Byfield JE, Murnane J, Ward JF, Calabro-Jones P, Lynch M, Kulhanian F.
    Br J Cancer; 1981 May; 43(5):669-83. PubMed ID: 7248151
    [Abstract] [Full Text] [Related]

  • 2. Effects of methylated xanthines on mammalian cells treated with bifunctional alkylating agents.
    Murnane JP, Byfield JE, Ward JF, Calabro-Jones P.
    Nature; 1980 May 29; 285(5763):326-9. PubMed ID: 7374784
    [Abstract] [Full Text] [Related]

  • 3. Theophylline does not reverse DNA replicon initiation inhibition in human cells resistant to alkylating agent-theophylline killing synergism.
    Ducore JM, Rosenstein BS.
    Chem Biol Interact; 1984 Sep 15; 51(2):191-200. PubMed ID: 6540627
    [Abstract] [Full Text] [Related]

  • 4. The structure of methylated xanthines in relation to their effects on DNA synthesis and cell lethality in nitrogen mustard-treated cells.
    Murnane JP, Byfield JE, Chen CT, Wang CH.
    Biophys J; 1981 Sep 15; 35(3):665-76. PubMed ID: 7272456
    [Abstract] [Full Text] [Related]

  • 5. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY, Teicher BA, Shea TC, Holden SA, Rosbe KW, al-Achi A, Henner WD.
    Cancer Res; 1989 Nov 15; 49(22):6185-92. PubMed ID: 2804968
    [Abstract] [Full Text] [Related]

  • 6. Base excision repair as a therapeutic target in colon cancer.
    Liu L, Nakatsuru Y, Gerson SL.
    Clin Cancer Res; 2002 Sep 15; 8(9):2985-91. PubMed ID: 12231545
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of DNA repair replication by DNA binding drugs which sensitize cells to alkylating agents and X-rays.
    Gaudin D, Gregg RS, Yielding KL.
    Proc Soc Exp Biol Med; 1972 Nov 15; 141(2):543-7. PubMed ID: 4636521
    [No Abstract] [Full Text] [Related]

  • 10. Cytotoxicity of alkylating agents towards sensitive and resistant strains of Escherichia coli in relation to extent and mode of alkylation of cellular macromolecules and repair of alkylation lesions in deoxyribonucleic acids.
    Lawley PD, Brookes P.
    Biochem J; 1968 Sep 15; 109(3):433-47. PubMed ID: 4879534
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxic, cell cycle, and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents.
    Fingert HJ, Chang JD, Pardee AB.
    Cancer Res; 1986 May 15; 46(5):2463-7. PubMed ID: 3084068
    [Abstract] [Full Text] [Related]

  • 12. Isolation of alkylating agent-sensitive Chinese hamster ovary cell lines.
    Robson CN, Hickson ID.
    Carcinogenesis; 1987 Apr 15; 8(4):601-5. PubMed ID: 3103949
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Flow cytometric analysis of DNA damage and repair in the cells resistant to alkylating agents.
    Frankfurt OS, Seckinger D, Sugarbaker EV.
    Cancer Res; 1990 Aug 01; 50(15):4453-7. PubMed ID: 2369722
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo.
    Teicher BA, Holden SA, Herman TS, Epelbaum R, Pardee AB, Dezube B.
    Anticancer Res; 1991 Aug 01; 11(4):1555-60. PubMed ID: 1746913
    [Abstract] [Full Text] [Related]

  • 19. Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.
    Shepherd R, Harrap KR.
    Br J Cancer; 1982 Mar 01; 45(3):413-20. PubMed ID: 7073935
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
    Nath K, Nelson DS, Putt ME, Leeper DB, Garman B, Nathanson KL, Glickson JD.
    PLoS One; 2016 Mar 01; 11(6):e0157125. PubMed ID: 27285585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.